
Novocuff secures $26M to advance tech combating preterm births.
Novocuff, Inc., a medical device company focused on enhancing pregnancy outcomes and minimizing the risk of preterm birth, has successfully concluded an oversubscribed $26 million Series A funding round following an initial $2 million seed round. AXA IM Alts led…











